Dianthus Therapeutics, Inc. · NASDAQ:DNTH

BlackRock, Inc. reported a 5.10% stake in Dianthus Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 27, 2026

BlackRock, Inc. reported a 5.10% stake in Dianthus Therapeutics, Inc., 2,634,004 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G).

Stake
5.10%
Shares
2,634,004
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.10%2,634,004

Source

View original at SEC

Related